Advertisement

Topics

Drugmakers' hopes for gene therapy rise despite tiny sales in Europe

02:26 EDT 8 Aug 2017 | Reuters

LONDON (Reuters) - The science of gene therapy is finally delivering on its potential, and drugmakers are now hoping to produce commercially viable medicines after tiny sales for the first two such treatments in Europe.

Original Article: Drugmakers' hopes for gene therapy rise despite tiny sales in Europe

NEXT ARTICLE

More From BioPortfolio on "Drugmakers' hopes for gene therapy rise despite tiny sales in Europe"

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...